{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:05:24Z","timestamp":1793145924239,"version":"4.5.0"},"reference-count":157,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008840","name":"Imam Muhammad Ibn Saud Islamic University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008840","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023673","name":"Deanship of Scientific Research, Imam Mohammed Ibn Saud Islamic University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002713","name":"Imam Mohammed Ibn Saud Islamic University","doi-asserted-by":"publisher","award":["IMSIU-DDRSP2601"],"award-info":[{"award-number":["IMSIU-DDRSP2601"]}],"id":[{"id":"10.13039\/501100002713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jmgm.2025.109271","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T07:30:25Z","timestamp":1767425425000},"page":"109271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Integrated QSAR, molecular docking, and dynamics-based discovery of a potent selective HDAC1 inhibitor with therapeutic potential in aggressive cancers"],"prefix":"10.1016","volume":"143","author":[{"given":"Sampada","family":"Shelke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3563-6642","authenticated-orcid":false,"given":"Rahul D.","family":"Jawarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravin N.","family":"Khatale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umang","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah Yahya Abdullah","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Samad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami A.","family":"Al-Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamal A.","family":"Al-Mutairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdi E.A.","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2025.109271_bib1","doi-asserted-by":"crossref","DOI":"10.1186\/1868-7083-4-5","article-title":"Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors","volume":"4","author":"Delcuve","year":"2012","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.jmgm.2025.109271_bib2","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1038\/sj.onc.1210610","article-title":"Histone deacetylases and cancer","volume":"26","author":"Glozak","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.jmgm.2025.109271_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.cr.7310149","article-title":"HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics","volume":"17","author":"Gallinari","year":"2007","journal-title":"Cell Res."},{"key":"10.1016\/j.jmgm.2025.109271_bib4","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.bbagrm.2010.05.008","article-title":"Histone deacetylase inhibitors: a chemical genetics approach to understanding cellular functions","volume":"1799","author":"Marks","year":"2010","journal-title":"Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms"},{"key":"10.1016\/j.jmgm.2025.109271_bib5","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s12276-020-0382-4","article-title":"A short guide to histone deacetylases including recent progress on class II enzymes","volume":"52","author":"Park","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jmgm.2025.109271_bib6","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1136\/jcp.2010.080952","article-title":"Expression of class I histone deacetylases (HDAC1 and HDAC2) in oesophageal adenocarcinomas: an immunohistochemical study","volume":"63","author":"Langer","year":"2010","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jmgm.2025.109271_bib7","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026831","article-title":"HDACs and HDAC inhibitors in cancer development and therapy","volume":"6","author":"Li","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jmgm.2025.109271_bib8","volume":"19","author":"Wang","year":"2020"},{"key":"10.1016\/j.jmgm.2025.109271_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.jmgm.2025.109271_bib10","first-page":"34","article-title":"RNA-seq analysis identified hormone-related genes associated with prognosis of triple negative breast cancer","author":"Chen","year":"2020","journal-title":"The Journal of Biomedical Research"},{"key":"10.1016\/j.jmgm.2025.109271_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ph15060667","article-title":"HDAC inhibitors for the therapy of triple negative breast cancer","volume":"15","author":"Maccallini","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jmgm.2025.109271_bib12","doi-asserted-by":"crossref","first-page":"114156","DOI":"10.18632\/oncotarget.23169","article-title":"HDAC inhibition potentiates immunotherapy in triple negative breast cancer","volume":"8","author":"Terranova-Barberio","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jmgm.2025.109271_bib13","first-page":"14","article-title":"Inhibition of histone deacetylases attenuates tumor progression and improves immunotherapy in breast cancer","author":"Lian","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jmgm.2025.109271_bib14","doi-asserted-by":"crossref","first-page":"48027","DOI":"10.18632\/oncotarget.18227","article-title":"Knockdown of HDAC1 expression suppresses invasion and induces apoptosis in glioma cells","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jmgm.2025.109271_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-024-01551-8","article-title":"Advances in targeting histone deacetylase for treatment of solid tumors","volume":"17","author":"Shi","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jmgm.2025.109271_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jid.2021.05.026","article-title":"HDAC1\/2 control proliferation and survival in adult Epidermis and pre\u2012basal cell carcinoma through p16 and p53","volume":"142","author":"Zhu","year":"2022","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jmgm.2025.109271_bib17","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/ijc.25151","article-title":"Type\u2010specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E\u2010cadherin","volume":"127","author":"Hayashi","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jmgm.2025.109271_bib18","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/s41594-023-01041-4","article-title":"Collateral lethality between HDAC1 and HDAC2 exploits cancer-specific NuRD complex vulnerabilities","volume":"30","author":"Zhang","year":"2023","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jmgm.2025.109271_bib19","article-title":"Diverse nucleosome Site-Selectivity among histone deacetylase complexes","volume":"9","author":"Wang","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.jmgm.2025.109271_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/genes11050556","article-title":"Histone deacetylases (HDACs): Evolution, specificity, role in transcriptional complexes, and pharmacological actionability","volume":"11","author":"Milazzo","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.jmgm.2025.109271_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.700947","article-title":"Characterization of histone deacetylase mechanisms in cancer development","volume":"11","author":"Hai","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jmgm.2025.109271_bib22","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/sj.bjc.6603463","article-title":"Cancer biology: mechanism of antitumour action of vorinostat (suberoylanilide hydroxamic acid), a novel histone deacetylase inhibitor","volume":"95","author":"Richon","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jmgm.2025.109271_bib23","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1016\/j.fertnstert.2010.04.052","article-title":"Romidepsin reduces histone deacetylase activity, induces acetylation of histones, inhibits proliferation, and activates apoptosis in immortalized epithelial endometriotic cells","volume":"94","author":"Imesch","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jmgm.2025.109271_bib24","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1523\/JNEUROSCI.4208-14.2015","article-title":"Costimulation of AMPA and metabotropic glutamate receptors underlies phospholipase C activation by glutamate in Hippocampus","volume":"35","author":"Kim","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jmgm.2025.109271_bib25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/B978-0-12-409547-2.12393-5","article-title":"Inhibitors of epigenetic regulation in cancer","volume":"III","author":"Harvey","year":"2017","journal-title":"Comprehensive Medicinal Chemistry"},{"key":"10.1016\/j.jmgm.2025.109271_bib26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.7150\/ijms.30154","article-title":"Histone deacetylases (HDACs) guided novel therapies for T-cell lymphomas","volume":"16","author":"Zhang","year":"2019","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.jmgm.2025.109271_bib27","first-page":"137","article-title":"Discovery of novel hit compounds as potential HDAC1 inhibitors: the case of ligand- and structure-based virtual screening","author":"Sirous","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.jmgm.2025.109271_bib28","doi-asserted-by":"crossref","first-page":"20003","DOI":"10.1073\/pnas.1013754107","article-title":"Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents","volume":"107","author":"Namdar","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jmgm.2025.109271_bib29","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1073\/pnas.0430973100","article-title":"Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation","volume":"100","author":"Haggarty","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jmgm.2025.109271_bib30","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1242\/jcs.03431","article-title":"HDAC6 deacetylation of tubulin modulates dynamics of cellular adhesions","volume":"120","author":"Tran","year":"2007","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jmgm.2025.109271_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ph17050620","article-title":"The histone deacetylase family: structural features and application of combined computational methods","volume":"17","author":"Curcio","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jmgm.2025.109271_bib32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/156802609788085287","article-title":"Computational studies on the histone deacetylases and the design of selective histone deacetylase inhibitors","volume":"9","author":"Wang","year":"2009","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109271_bib33","first-page":"123","article-title":"Pharmacophore-enabled virtual screening, molecular docking and molecular dynamics studies for identification of potent and selective histone deacetylase 8 inhibitors","author":"Kashyap","year":"2020","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.jmgm.2025.109271_bib34","doi-asserted-by":"crossref","DOI":"10.1186\/1868-7083-3-4","article-title":"Dietary phytochemicals, HDAC inhibition, and DNA damage\/repair defects in cancer cells","volume":"3","author":"Rajendran","year":"2011","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.jmgm.2025.109271_bib35","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.3390\/ijms10115002","article-title":"Methylation of dietary flavones increases their metabolic stability and chemopreventive effects","volume":"10","author":"Walle","year":"2009","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmgm.2025.109271_bib36","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/med.21876","article-title":"Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: helping to fight against cancer via multiple targets","volume":"42","author":"Zhong","year":"2022","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jmgm.2025.109271_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119504","article-title":"Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy","volume":"277","author":"Ramaiah","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.jmgm.2025.109271_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00428","article-title":"Angiogenesis inhibitors for the treatment of hepatocellular carcinoma","volume":"7","author":"Berretta","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jmgm.2025.109271_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109573","article-title":"The multi-kinase inhibitor lenvatinib interacts with the HDAC inhibitor entinostat to kill liver cancer cells","volume":"70","author":"Roberts","year":"2020","journal-title":"Cell. Signal."},{"key":"10.1016\/j.jmgm.2025.109271_bib40","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.7150\/ijbs.93375","article-title":"HDAC inhibition sensitize hepatocellular carcinoma to lenvatinib via suppressing AKT activation","volume":"20","author":"Yan","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.jmgm.2025.109271_bib41","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s12072-023-10484-2","article-title":"Synergistic antitumor effect of histone deacetylase class IIa inhibitor with lenvatinib in hepatocellular carcinoma","volume":"17","author":"Ito","year":"2023","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.jmgm.2025.109271_bib42","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1111\/bcp.14889","article-title":"Recent developments of HDAC inhibitors: emerging indications and novel molecules","volume":"87","author":"Bondarev","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jmgm.2025.109271_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400194","article-title":"Heterocycles\u2013Containing HDAC inhibitors active in cancer: an overview of the last fifteen years","volume":"19","author":"Raucci","year":"2024","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jmgm.2025.109271_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/mog2.59","article-title":"Epigenetic regulation in cancer therapy: from mechanisms to clinical advances","volume":"3","author":"Tao","year":"2024","journal-title":"MedComm \u2013 Oncology"},{"key":"10.1016\/j.jmgm.2025.109271_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-024-01803-z","article-title":"Cancer epigenetics: from laboratory studies and clinical trials to precision medicine","volume":"10","author":"Yu","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.jmgm.2025.109271_bib46","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/febs.15750","article-title":"Clinical advances in targeting epigenetics for cancer therapy","volume":"289","author":"Feng","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.jmgm.2025.109271_bib47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jmgm.2016.09.008","article-title":"A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study","volume":"70","author":"Choubey","year":"2016","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2025.109271_bib48","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.molstruc.2016.06.082","article-title":"Identification of novel histone deacetylase 1 inhibitors by combined pharmacophore modeling, 3D-QSAR analysis, in silico screening and Density Functional Theory (DFT) approaches","volume":"1125","author":"Choubey","year":"2016","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jmgm.2025.109271_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/med.20200","article-title":"Histone deacetylase inhibitors (HDACIs). Structure\u2014Activity relationships: history and new QSAR perspectives","volume":"32","author":"Pontiki","year":"2011","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jmgm.2025.109271_bib50","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/qsar.200610151","article-title":"Principles of QSAR models validation: internal and external","volume":"26","author":"Gramatica","year":"2007","journal-title":"QSAR Comb. Sci."},{"key":"10.1016\/j.jmgm.2025.109271_bib51","doi-asserted-by":"crossref","DOI":"10.1186\/s13321-015-0082-6","article-title":"QSAR DataBank repository: open and linked qualitative and quantitative structure\u2013activity relationship models","volume":"7","author":"Ruusmann","year":"2015","journal-title":"J. Cheminf."},{"key":"10.1016\/j.jmgm.2025.109271_bib52","first-page":"1245","article-title":"A computational approach to discover potential quinazoline derivatives against CDK4\/6 kinase","author":"Anant","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jmgm.2025.109271_bib53","series-title":"Molecular Descriptors for Chemoinformatics","year":"2009"},{"key":"10.1016\/j.jmgm.2025.109271_bib54","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1517\/17460441.2010.492827","article-title":"Advances in computational methods to predict the biological activity of compounds","volume":"5","author":"Nantasenamat","year":"2010","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.jmgm.2025.109271_bib55","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-019-3135-4","article-title":"Comprehensive ensemble in QSAR prediction for drug discovery","volume":"20","author":"Kwon","year":"2019","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.jmgm.2025.109271_bib56","doi-asserted-by":"crossref","DOI":"10.1186\/s13321-015-0093-3","article-title":"Standards-based curation of a decade-old digital repository dataset of molecular information","volume":"7","author":"Harvey","year":"2015","journal-title":"J. Cheminf."},{"key":"10.1016\/j.jmgm.2025.109271_bib57","doi-asserted-by":"crossref","first-page":"25","DOI":"10.22270\/ijdra.v8i4.431","article-title":"Understanding OECD Guidelines for QSAR Models-A Software development and harmonization strategy","volume":"8","author":"Bayya","year":"2020","journal-title":"International Journal of Drug Regulatory Affairs"},{"key":"10.1016\/j.jmgm.2025.109271_bib58","first-page":"158","article-title":"Marvin: a tool kit for streamlined access and visualization of the SDSS-IV MaNGA data set","author":"Cherinka","year":"2019","journal-title":"Astron. J."},{"key":"10.1016\/j.jmgm.2025.109271_bib59","doi-asserted-by":"crossref","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminf."},{"key":"10.1016\/j.jmgm.2025.109271_bib60","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2025.109271_bib61","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1093\/bioinformatics\/btaa018","article-title":"LigRMSD: a web server for automatic structure matching and RMSD calculations among identical and similar compounds in protein-ligand docking","volume":"36","author":"Vel\u00e1zquez-Libera","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jmgm.2025.109271_bib62","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4236\/mri.2019.83003","article-title":"Thrombolytic activity, drug likeness property and ADME\/T analysis of isolated phytochemicals from ginger (Zingiber officinale) using In Silico approaches","volume":"8","author":"Hossain","year":"2019","journal-title":"Mod. Res. Inflamm."},{"key":"10.1016\/j.jmgm.2025.109271_bib63","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.chemolab.2017.08.003","article-title":"A new PyMOL plugin for calculating thousands of easily understandable molecular descriptors","volume":"169","author":"Masand","year":"2017","journal-title":"Chemometr. Intell. Lab. Syst."},{"key":"10.1016\/j.jmgm.2025.109271_bib64","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1002\/jcc.23387","article-title":"Ab initio study of the high\u2010temperature phase transition in crystalline GeO2","volume":"34","author":"Deringer","year":"2013","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2025.109271_bib65","first-page":"52","article-title":"Computational QSAR model combined molecular descriptors and fingerprints to predict HDAC1 inhibitors","volume":"34","author":"Shi","year":"2018","journal-title":"M-S (Med. Sci.)"},{"key":"10.1016\/j.jmgm.2025.109271_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e06605","article-title":"Pharmacophore model, docking, QSAR, and molecular dynamics simulation studies of substituted cyclic imides and herbal medicines as COX-2 inhibitors","volume":"7","author":"Moussa","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.jmgm.2025.109271_bib67","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.matpr.2020.08.044","article-title":"QSAR modeling, molecular docking studies and ADMET prediction on a series of phenylaminopyrimidine-(thio) urea derivatives as CK2 inhibitors","volume":"51","author":"Goudzal","year":"2022","journal-title":"Mater. Today Proc."},{"key":"10.1016\/j.jmgm.2025.109271_bib68","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1021\/ci400573c","article-title":"Choosing feature selection and learning algorithms in QSAR","volume":"54","author":"Eklund","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2025.109271_bib69","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3109\/14756361003757893","article-title":"Quantitative structure\u2013activity relationship (QSAR) study of interleukin-1 receptor associated kinase 4 (IRAK-4) inhibitor activity by the genetic algorithm and multiple linear regression (GA-MLR) method","volume":"25","author":"Pourbasheer","year":"2010","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109271_bib70","doi-asserted-by":"crossref","DOI":"10.1186\/s13321-014-0047-1","article-title":"Reliable estimation of prediction errors for QSAR models under model uncertainty using double cross-validation","volume":"6","author":"Baumann","year":"2014","journal-title":"J. Cheminf."},{"key":"10.1016\/j.jmgm.2025.109271_bib71","doi-asserted-by":"crossref","DOI":"10.1186\/s13321-021-00519-x","article-title":"Benchmarks for interpretation of QSAR models","volume":"13","author":"Matveieva","year":"2021","journal-title":"J. Cheminf."},{"key":"10.1016\/j.jmgm.2025.109271_bib72","doi-asserted-by":"crossref","first-page":"436","DOI":"10.5530\/ijper.51.3.72","article-title":"SWFB and GA strategies for variable selection in QSAR studies for the validation of Thiazolidine- 2,4-Dione derivatives as promising antitumor candidates","volume":"51","author":"Asati","year":"2017","journal-title":"Indian Journal of Pharmaceutical Education and Research"},{"key":"10.1016\/j.jmgm.2025.109271_bib73","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2174\/138620711795767893","article-title":"On various metrics used for validation of predictive QSAR models with applications in virtual screening and focused Library design","volume":"14","author":"Roy","year":"2011","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.jmgm.2025.109271_bib74","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.3390\/molecules16031928","article-title":"QSAR models for CXCR2 receptor antagonists based on the genetic Algorithm for data preprocessing prior to application of the PLS linear regression method and design of the new compounds using in Silico virtual screening","volume":"16","author":"Asadollahi","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2025.109271_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14071415","article-title":"Do AutoML-Based QSAR models fulfill OECD principles for regulatory assessment? A 5-HT1A receptor case","volume":"14","author":"Czub","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jmgm.2025.109271_bib76","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1021\/acs.jcim.5b00206","article-title":"Beware of R2: simple, unambiguous assessment of the prediction accuracy of QSAR and QSPR models","volume":"55","author":"Alexander","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2025.109271_bib77","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1021\/ci200211n","article-title":"Real external predictivity of QSAR models: how to evaluate it? Comparison of different validation criteria and proposal of using the concordance correlation coefficient","volume":"51","author":"Chirico","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2025.109271_bib78","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.molstruc.2016.12.006","article-title":"3D-QSAR and virtual screening studies of thiazolidine-2,4-dione analogs: validation of experimental inhibitory potencies towards PIM-1 kinase","volume":"1133","author":"Asati","year":"2017","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jmgm.2025.109271_bib79","article-title":"On the misleading use of for QSAR model comparison","volume":"38","author":"Consonni","year":"2018","journal-title":"Molecular Informatics"},{"key":"10.1016\/j.jmgm.2025.109271_bib80","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1021\/ci700157b","article-title":"Randomization and its variants in QSPR\/QSAR","volume":"47","author":"R\u00fccker","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2025.109271_bib81","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1093-3263(01)00123-1","article-title":"Beware of q2","volume":"20","author":"Golbraikh","year":"2002","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2025.109271_bib82","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.fct.2014.03.035","article-title":"Predicting the bioconcentration factor of highly hydrophobic organic chemicals","volume":"69","author":"Garg","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.jmgm.2025.109271_bib83","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4018\/IJQSPR.2016010102","article-title":"Applicability Domain for QSAR models","volume":"1","author":"Gadaleta","year":"2016","journal-title":"International Journal of Quantitative Structure-Property Relationships"},{"key":"10.1016\/j.jmgm.2025.109271_bib84","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/jcc.23576","article-title":"QSARINS\u2010chem: insubria datasets and new QSAR\/QSPR models for environmental pollutants in QSARINS","volume":"35","author":"Gramatica","year":"2014","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2025.109271_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27061845","article-title":"QSAR and molecular docking studies of pyrimidine-coumarin-triazole conjugates as prospective anti-breast cancer agents","volume":"27","author":"Subramani","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2025.109271_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03449","article-title":"QSAR and molecular docking studies of 1,3-dioxoisoindoline-4-aminoquinolines as potent antiplasmodium hybrid compounds","volume":"6","author":"Mahmud","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.jmgm.2025.109271_bib87","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/slct.201702392","article-title":"Virtual screening, molecular docking, and DFT studies of some Thiazolidine\u20102,4\u2010diones as potential PIM\u20101 kinase inhibitors","volume":"3","author":"Asati","year":"2018","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.jmgm.2025.109271_bib88","first-page":"1287","article-title":"Identification of potential N-substituted 5-benzylidenethiazolidine-2,4-dione derivatives as \u03b1-amylase inhibitors: computational cum synthetic studies","author":"Gupta","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jmgm.2025.109271_bib89","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2025.109271_bib90","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jbiotec.2018.09.003","article-title":"Identification of an alternative translation initiation site in the sequence of the commonly used Glutathione S-Transferase tag","volume":"286","author":"Bernier","year":"2018","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jmgm.2025.109271_bib91","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1093\/bioinformatics\/btv458","article-title":"NRGsuite: a PyMOL plugin to perform docking simulations in real time using FlexAID","volume":"31","author":"Gaudreault","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jmgm.2025.109271_bib92","first-page":"7","article-title":"Identification of coumarin derivatives targeting acetylcholinesterase for Alzheimer's disease by field-based 3D-QSAR, pharmacophore model-based virtual screening, molecular docking, MM\/GBSA, ADME and MD Simulation study","author":"Saha","year":"2024","journal-title":"Current Research in Structural Biology"},{"key":"10.1016\/j.jmgm.2025.109271_bib93","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1021\/ct200908r","article-title":"Optimization of the OPLS-AA force field for long hydrocarbons","volume":"8","author":"Siu","year":"2012","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.jmgm.2025.109271_bib94","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: a force field providing broad coverage of drug-like small molecules and proteins","volume":"12","author":"Harder","year":"2015","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.jmgm.2025.109271_bib95","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.1021\/acs.jctc.7b00520","article-title":"Revisiting OPLS force field parameters for ionic liquid simulations","volume":"13","author":"Doherty","year":"2017","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.jmgm.2025.109271_bib96","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1021\/acs.jctc.8b00909","article-title":"Optimizing nonbonded interactions of the OPLS force field for aqueous solutions of carbohydrates: how to capture both thermodynamics and dynamics","volume":"14","author":"Jamali","year":"2018","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.jmgm.2025.109271_bib97","article-title":"Best practices for foundations in molecular simulations [article v1.0]","volume":"1","author":"Braun","year":"2019","journal-title":"Living Journal of Computational Molecular Science"},{"key":"10.1016\/j.jmgm.2025.109271_bib98","doi-asserted-by":"crossref","DOI":"10.1186\/s42269-021-00541-x","article-title":"QSAR, molecular docking studies, ligand-based design and pharmacokinetic analysis on Maternal Embryonic Leucine Zipper Kinase (MELK) inhibitors as potential anti-triple-negative breast cancer (MDA-MB-231 cell line) drug compounds","volume":"45","author":"Lawal","year":"2021","journal-title":"Bull. Natl. Res. Cent."},{"key":"10.1016\/j.jmgm.2025.109271_bib99","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-019-0108-8","article-title":"Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT\u2013tamoxifen hybrid therapy","volume":"5","author":"Theodossiou","year":"2019","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.jmgm.2025.109271_bib100","first-page":"26","article-title":"Insights into the behavior of triple-negative MDA-MB-231 breast carcinoma cells following the treatment with 17\u03b2-Ethinylestradiol and levonorgestrel","author":"Simu","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2025.109271_bib101","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.21873\/anticanres.13410","article-title":"The triple-negative breast cancer cell line MDA-MB 231 is specifically inhibited by the ionophore Salinomycin","volume":"39","author":"Hero","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jmgm.2025.109271_bib102","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/sj.bjc.6600985","article-title":"Inhibition of epidermoid carcinoma A431 cell growth and angiogenesis in nude mice by early and late treatment with a novel dextran derivative","volume":"88","author":"Di Benedetto","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jmgm.2025.109271_bib103","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/jcp.1041270121","article-title":"EGF induces cell cycle arrest of A431 human epidermoid carcinoma cells","volume":"127","author":"MacLeod","year":"2005","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jmgm.2025.109271_bib104","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.biopha.2013.03.012","article-title":"Icotinib, a potent and specific EGFR tyrosine kinase inhibitor, inhibits growth of squamous cell carcinoma cell line A431 through negatively regulating AKT signaling","volume":"67","author":"Gao","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jmgm.2025.109271_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27154758","article-title":"QSAR evaluations to unravel the structural features in lysine-specific histone demethylase 1A inhibitors for novel anticancer lead development supported by Molecular Docking, MD simulation and MMGBSA","volume":"27","author":"Jawarkar","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2025.109271_bib106","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.chemolab.2016.01.008","article-title":"Be aware of error measures. Further studies on validation of predictive QSAR models","volume":"152","author":"Roy","year":"2016","journal-title":"Chemometr. Intell. Lab. Syst."},{"key":"10.1016\/j.jmgm.2025.109271_bib107","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22101671","article-title":"Predictive QSAR models for the toxicity of disinfection byproducts","volume":"22","author":"Qin","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2025.109271_bib108","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0098-3004(93)90090-R","article-title":"Principal components analysis (PCA)","volume":"19","author":"Ma\u0107kiewicz","year":"1993","journal-title":"Comput. Geosci."},{"key":"10.1016\/j.jmgm.2025.109271_bib109","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11030-006-9024-6","article-title":"Megavariate analysis of environmental QSAR data. Part I \u2013 a basic framework founded on principal component analysis (PCA), partial least squares (PLS), and statistical molecular design (SMD)","volume":"10","author":"Eriksson","year":"2006","journal-title":"Mol. Divers."},{"key":"10.1016\/j.jmgm.2025.109271_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0169-7439(96)00023-8","article-title":"Multivariate design and modeling in QSAR","volume":"34","author":"Eriksson","year":"1996","journal-title":"Chemometr. Intell. Lab. Syst."},{"key":"10.1016\/j.jmgm.2025.109271_bib111","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.chemolab.2009.05.006","article-title":"Dimensionality reduction for metabolome data using PCA, PLS, OPLS, and RFDA with differential penalties to latent variables","volume":"98","author":"Yamamoto","year":"2009","journal-title":"Chemometr. Intell. Lab. Syst."},{"key":"10.1016\/j.jmgm.2025.109271_bib112","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1080\/07391102.2018.1441072","article-title":"Insights into structural features of HDAC1 and its selectivity inhibition elucidated by molecular dynamic simulation and molecular Docking","volume":"37","author":"Sixto-L\u00f3pez","year":"2018","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2025.109271_bib113","article-title":"Balancing histone deacetylase (HDAC) inhibition and drug\u2010likeness: biological and physicochemical evaluation of class I selective HDAC inhibitors","volume":"17","author":"Sch\u00e4ker\u2010H\u00fcbner","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jmgm.2025.109271_bib114","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-02114-3","article-title":"Hybridizing feature selection and feature learning approaches in QSAR modeling for drug discovery","volume":"7","author":"Ponzoni","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2025.109271_bib115","first-page":"135","article-title":"Synergizing GA-XGBoost and QSAR modeling: breaking down activity cliffs in HDAC1 inhibitors","author":"Jawarkar","year":"2025","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2025.109271_bib116","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26071834","article-title":"QSAR and pharmacophore modeling of nitrogen heterocycles as potent human N-Myristoyltransferase (Hs-NMT) inhibitors","volume":"26","author":"Zaki","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2025.109271_bib117","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejmech.2012.10.035","article-title":"Combining QSAR classification models for predictive modeling of human monoamine oxidase inhibitors","volume":"59","author":"Helguera","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109271_bib118","doi-asserted-by":"crossref","DOI":"10.1007\/s00894-022-05103-0","article-title":"Identification of potent HDAC 2 inhibitors using E-pharmacophore modelling, structure-based virtual screening and molecular dynamic simulation","volume":"28","author":"Pai","year":"2022","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.jmgm.2025.109271_bib119","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.gene.2017.09.034","article-title":"Design, virtual screening, molecular docking and molecular dynamics studies of novel urushiol derivatives as potential HDAC2 selective inhibitors","volume":"637","author":"Zhou","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.jmgm.2025.109271_bib120","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1016\/j.bmc.2016.06.040","article-title":"Kinetic and structural insights into the binding of histone deacetylase 1 and 2 (HDAC1, 2) inhibitors","volume":"24","author":"Wagner","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109271_bib121","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.chembiol.2013.03.020","article-title":"Selective HDAC1\/HDAC2 inhibitors induce neuroblastoma differentiation","volume":"20","author":"Frumm","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.jmgm.2025.109271_bib122","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1021\/acschembio.3c00427","article-title":"Development of potent dual BET\/HDAC inhibitors via pharmacophore merging and structure-guided optimization","volume":"19","author":"Bauer","year":"2024","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jmgm.2025.109271_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2022.03.002","article-title":"Resolving the deceptive isoform and complex selectivity of HDAC1\/2 inhibitors","volume":"29","author":"Payne","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jmgm.2025.109271_bib124","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.chembiol.2014.12.015","article-title":"Identification of histone deacetylase inhibitors with benzoylhydrazide scaffold that selectively inhibit class I histone deacetylases","volume":"22","author":"Wang","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.jmgm.2025.109271_bib125","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26154617","article-title":"Nitrogen-Containing heterocycles as significant molecular scaffolds for medicinal and other applications","volume":"26","author":"Frank","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2025.109271_bib126","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/pro.2955","article-title":"Analysis of the interactions of sulfur\u2010containing amino acids in membrane proteins","volume":"25","author":"G\u00f3mez\u2010Tamayo","year":"2016","journal-title":"Protein Sci."},{"key":"10.1016\/j.jmgm.2025.109271_bib127","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2012.0835","article-title":"On the binding affinity of macromolecular interactions: daring to ask why proteins interact","volume":"10","author":"Kastritis","year":"2013","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.jmgm.2025.109271_bib128","series-title":"Post-Translational Modifications that Modulate Enzyme Activity","first-page":"447","article-title":"Methods for the expression, purification, and crystallization of histone deacetylase 6\u2013inhibitor complexes","author":"Osko","year":"2019"},{"key":"10.1016\/j.jmgm.2025.109271_bib129","doi-asserted-by":"crossref","first-page":"9969","DOI":"10.1021\/jm401225q","article-title":"Synthesis and structure\u2013activity relationship of 3-Hydroxypyridine-2-thione-Based histone deacetylase inhibitors","volume":"56","author":"Sodji","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109271_bib130","doi-asserted-by":"crossref","DOI":"10.3987\/R-1985-07-1765","article-title":"Mechanisms of nucleophilic displacements at sp3 hybridized carbon atoms with heterocyclic leaving groups","volume":"23","author":"R. Katritzky","year":"1985","journal-title":"Heterocycles."},{"key":"10.1016\/j.jmgm.2025.109271_bib131","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/1573409914666180502113135","article-title":"Identification of Hydroxamic acid based selective HDAC1 inhibitors: computer aided drug design studies","volume":"15","author":"Patel","year":"2019","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.jmgm.2025.109271_bib132","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202404466","article-title":"Development of Novel hydroxy amide\u2010based HDAC1 inhibitors: integrated pharmacophore modelling, 3D\u2010QSAR, and virtual screening studies","volume":"9","author":"Saha","year":"2024","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.jmgm.2025.109271_bib133","first-page":"1","volume":"22","author":"G\u00f6cen","year":"2022"},{"key":"10.1016\/j.jmgm.2025.109271_bib134","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2017.00357","article-title":"Combinatorial in Silico strategy towards identifying potential hotspots during inhibition of structurally identical HDAC1 and HDAC2 enzymes for effective chemotherapy against neurological disorders","volume":"10","author":"Ganai","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jmgm.2025.109271_bib135","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1080\/1062936X.2022.2145353","article-title":"A quantitative structural analysis of AR-42 derivatives as HDAC1 inhibitors for the identification of promising structural contributors","volume":"33","author":"Kundu","year":"2022","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.jmgm.2025.109271_bib136","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1021\/acs.accounts.3c00801","article-title":"Chemical versatility in catalysis and inhibition of the class IIb histone deacetylases","volume":"57","author":"Christianson","year":"2024","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jmgm.2025.109271_bib137","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/jm021070e","article-title":"3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-alkylamides as a new class of synthetic histone deacetylase inhibitors. 1. Design, synthesis, biological evaluation, and binding mode studies performed through three different docking procedures","volume":"46","author":"Mai","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109271_bib138","doi-asserted-by":"crossref","DOI":"10.1038\/s42005-020-00425-y","article-title":"Electronic decoupling of polyacenes from the underlying metal substrate by sp3 carbon atoms","volume":"3","author":"Mohammed","year":"2020","journal-title":"Commun. Phys."},{"key":"10.1016\/j.jmgm.2025.109271_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2024.2442756","article-title":"Nitrogen-containing heterocycles as important scaffold for selective and potent HDAC8 inhibition: a step towards effective, non-toxic and selective HDAC8 inhibitor discovery","author":"Khatun","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2025.109271_bib140","article-title":"Design of novel small molecules derived from styrylpyridine as potent HDAC1 inhibitors for the treatment of gastric cancer using 3D-QSAR, drug similarity, ADMET prediction, molecular docking, and molecular dynamics studies","volume":"23","author":"Haloui","year":"2024","journal-title":"Sci. Afr."},{"key":"10.1016\/j.jmgm.2025.109271_bib141","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/1568009622666220624090542","article-title":"Recent progress in histone deacetylase (HDAC) 1 inhibitors as anticancer agent","volume":"23","author":"Patel","year":"2023","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.jmgm.2025.109271_bib142","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/cmdc.200900082","article-title":"Pyrrole\u2010Based hydroxamates and 2\u2010Aminoanilides: histone deacetylase inhibition and cellular activities","volume":"4","author":"Valente","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jmgm.2025.109271_bib143","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1021\/ja00316a034","article-title":"Directional hydrogen bonding to sp2- and sp3-hybridized oxygen atoms and its relevance to ligand-macromolecule interactions","volume":"106","author":"Murray-Rust","year":"2002","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmgm.2025.109271_bib144","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/cmdc.202000934","article-title":"Strategies to design selective histone deacetylase inhibitors","volume":"16","author":"Melesina","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jmgm.2025.109271_bib145","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.ejmech.2010.01.010","article-title":"Investigation on the isoform selectivity of histone deacetylase inhibitors using chemical feature based pharmacophore and docking approaches","volume":"45","author":"Zhu","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109271_bib146","first-page":"276","article-title":"Overview of class I HDAC modulators: inhibitors and degraders","author":"Huang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109271_bib147","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.ejmech.2010.02.030","article-title":"Inside HDAC with HDAC inhibitors","volume":"45","author":"Bertrand","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109271_bib148","series-title":"Computational Methods for Rational Drug Design","first-page":"123","article-title":"ADMET and physicochemical assessments in drug design","author":"\u00c7evik","year":"2025"},{"key":"10.1016\/j.jmgm.2025.109271_bib149","series-title":"Reviews in Computational Chemistry","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/0471678856.ch6","article-title":"Development of computational models for enzymes, transporters, channels, and receptors relevant to ADME\/Tox","author":"Ekins","year":"2004"},{"key":"10.1016\/j.jmgm.2025.109271_bib150","series-title":"Analyzing Oxygen Atom Distribution in Fda\u2010Approved Drugs to Enhance Drug Discovery Strategies","first-page":"105","author":"Masand","year":"2025"},{"key":"10.1016\/j.jmgm.2025.109271_bib151","doi-asserted-by":"crossref","first-page":"8831","DOI":"10.1080\/07391102.2023.2248509","article-title":"Fragment-based structural exploration and chemico-biological interaction study of HDAC3 inhibitors through Non-linear pattern recognition, chemical space, and binding mode of interaction analysis","volume":"42","author":"Banerjee","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2025.109271_bib152","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/1062936X.2024.2350504","article-title":"Exploring different classification-dependent QSAR modelling strategies for HDAC3 inhibitors in search of meaningful structural contributors","volume":"35","author":"Jha","year":"2024","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.jmgm.2025.109271_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2024.108376","article-title":"Unlocking the potential of enzyme engineering via rational computational design strategies","volume":"73","author":"Zhou","year":"2024","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jmgm.2025.109271_bib154","doi-asserted-by":"crossref","DOI":"10.3390\/ph16121639","article-title":"A review on molecular docking on HDAC isoforms: novel tool for designing selective inhibitors","volume":"16","author":"Drakontaeidi","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jmgm.2025.109271_bib155","doi-asserted-by":"crossref","DOI":"10.3390\/ph18020217","article-title":"Computational modeling of pharmaceuticals with an emphasis on crossing the blood\u2013brain barrier","volume":"18","author":"Alves","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jmgm.2025.109271_bib156","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15112619","article-title":"The trends and future prospective of in silico models from the viewpoint of ADME evaluation in drug discovery","volume":"15","author":"Komura","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jmgm.2025.109271_bib157","article-title":"Inhibiting HDAC1 enhances the anti-cancer effects of statins through downregulation of GGTase-I\u03b2 expression","volume":"18","author":"Li","year":"2017","journal-title":"Int. J. Mol. Sci."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326325003316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326325003316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T20:47:28Z","timestamp":1773953248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326325003316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":157,"alternative-id":["S1093326325003316"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2025.109271","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated QSAR, molecular docking, and dynamics-based discovery of a potent selective HDAC1 inhibitor with therapeutic potential in aggressive cancers","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2025.109271","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109271"}}